Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
On July 16, 2024, the U.S. House of Representatives oversight panel announced a hearing next week with executives from three major pharmacy benefit managers (PBMs) – OptumRx, Express Scripts, and CVS Health. The hearing, spearheaded by Rep. James Comer and the GOP Oversight Committee, aims to investigate the role of PBMs in rising healthcare costs. This comes after House Democrats passed legislation to lower prescription drug costs and reduce the deficit, a move that pharmaceutical corporations have unsuccessfully tried to overturn. Both Republicans and Democrats have raised concerns about the self-benefitting policies of PBMs that prioritize their profits over patients' needs.
🚨 Self-benefitting policies pushed by Pharmacy Benefit Managers serve to help their bottom line rather than patients. Republicans & Democrats have sounded the alarm over PBMs & their role in rising drug prices. @GOPoversight is working to hold PBMs accountable next week.👇 https://t.co/Eb70beeWFF
🔵 US HOUSE PANEL TO HOLD HEARING WITH PHARMACY BENEFIT MANAGERS ON HEALTHCARE COSTS The U.S. House of Representatives oversight panel said on Tuesday it will hold a hearing with executives from U.S. pharmacy benefit managers on the role of the firms in rising healthcare costs.…
📺NEXT WEEK📺 Comer Announces Hearing with PBM Executives on Role in Rising Health Care Costs https://t.co/fo2zVzyWqv